At 7 days after SCI, a significant improvement in BMS score was observed in the intravenous injection subgroup (SMD = 0.82, 95% CI = 0.04 to 1.60, p = 0.04), whereas the non-intravenous injection subgroup did not reach statistical significance (SMD = 2.76, 95% CI = -1.91 to 7.42, p = 0.25).
← all excerpts
Protective effect and possible mechanisms of resveratrol in animal models of spinal cord injury: a preclinical systematic review and meta-analysis.
1
0.2500
0.2500